The indirect activators of PI 3-kinase C2β, as listed above, are primarily inhibitors of various PI3K isoforms and related pathways. These compounds, though not directly activating PI 3-kinase C2β, are crucial for understanding the regulation and functional context of this kinase. PI 3-kinase C2β is part of the larger PI3K family, which plays a pivotal role in intracellular signaling related to growth, proliferation, and survival. By studying the effects of these inhibitors, one can gain insights into potential mechanisms of PI 3-kinase C2β regulation and activity.
Compounds like LY294002, Wortmannin, and GDC-0941, which are broad PI3K inhibitors, are valuable in studying the overarching influence of PI3K signaling on cellular processes, thereby providing indirect information about PI 3-kinase C2β. These inhibitors help in delineating the role of PI3Ks in various cellular contexts, which is crucial for understanding the specific functions of PI 3-kinase C2β. Additionally, isoform-specific inhibitors such as TGX-221, IC87114, and CAL-101 allow for a more nuanced understanding of how different PI3K isoforms interact and regulate diverse cellular pathways, potentially influencing PI 3-kinase C2β indirectly.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
While primarily a PI3K inhibitor, LY294002's broad activity may provide insights into PI 3-kinase C2β modulation by affecting related PI3K pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor; Wortmannin might influence PI 3-kinase C2β indirectly due to its role in PI3K signaling. | ||||||
PIK-93 | 593960-11-3 | sc-364588 | 5 mg | $255.00 | ||
PIK-93 is known to inhibit PIKfyve and Class IA PI3Ks, which could indirectly affect PI 3-kinase C2β activity. | ||||||
IC-87114 | 371242-69-2 | sc-364509 sc-364509A | 5 mg 50 mg | $140.00 $1060.00 | 1 | |
A selective inhibitor of PI3Kδ, IC87114's effects on signaling pathways might offer indirect insights into PI 3-kinase C2β activity. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $184.00 $195.00 | 2 | |
As a broad PI3K inhibitor, GDC-0941 could provide indirect information on PI 3-kinase C2β modulation. | ||||||
ZSTK 474 | 475110-96-4 | sc-475495 | 5 mg | $75.00 | ||
This pan-PI3K inhibitor might indirectly influence PI 3-kinase C2β through its broad activity on PI3K-related pathways. | ||||||
BAY 80-6946 | 1032568-63-0 | sc-503264 | 5 mg | $551.00 | ||
A PI3K inhibitor with activity against PI3Kα and δ isoforms, potentially impacting PI 3-kinase C2β indirectly. | ||||||
IPI 145 | 1201438-56-3 | sc-488318 | 5 mg | $311.00 | ||
As a PI3Kγ and δ inhibitor, Duvelisib might offer indirect insights into PI 3-kinase C2β activity. | ||||||
BYL719 | 1217486-61-7 | sc-391001 sc-391001A sc-391001B sc-391001C sc-391001D sc-391001E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $383.00 $585.00 $740.00 $1169.00 $4902.00 $9186.00 | 2 | |
A PI3Kα inhibitor, Alpelisib's influence on PI3K pathways could indirectly affect PI 3-kinase C2β. | ||||||